Research on SCID is ongoing, with scientists exploring various avenues to improve diagnosis, treatment, and outcomes. Current research focuses on gene therapy, which has shown promise in early clinical trials. Additionally, researchers are investigating new methods to enhance the effectiveness and safety of HSCT and enzyme replacement therapies.
